Rankings
▼
Calendar
BBOT Q2 2024 Earnings — BridgeBio Oncology Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BBOT
BridgeBio Oncology Therapeutics Inc.
$820M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$24M
Net Income
-$22M
EPS (Diluted)
$0.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$29,099
Free Cash Flow
-$29,099
Stock-Based Comp.
$77,400
Balance Sheet
Total Assets
$190M
Total Liabilities
$6M
Stockholders' Equity
$184M
Cash & Equivalents
$2M
← FY 2024
All Quarters
Q3 2024 →
